Open study of clarithromycin for the treatment of infections caused by nontuberculous mycobacteria (NTM)

Trial Profile

Open study of clarithromycin for the treatment of infections caused by nontuberculous mycobacteria (NTM)

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 May 2017

At a glance

  • Drugs Clarithromycin (Primary)
  • Indications Mycobacterial infections; Mycobacterium avium complex infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2017 Status changed from active, no longer recruiting to completed.
    • 29 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top